Printer Friendly

50 Stocks Moving In Thursday's Mid-Day Session.

Byline: Lisa Levin

Gainers

* Anika Therapeutics, Inc.(NASDAQ: ANIK) surged 35.1% to $55.15 after the company reported better-than-expected Q2 sales results.

* TCR2 Therapeutics Inc.(NASDAQ: TCRR) gained 30.1% to $13.20.

* Diebold Nixdorf, Incorporated (NYSE:DBD) rose 24.5% to $12.81 after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 sales guidance.

* Gemphire Therapeutics Inc.(NASDAQ: GEMP) shares climbed 22% to $0.8540 after the company announced a merger with NeuroBO Pharmaceuticals.

* Hovnanian Enterprises, Inc.(NYSE:HOV) rose 22% to $7.10.

* Rekor Systems, Inc.(NASDAQ: REKR) gained 20.5% to $4.82.

* EDAP TMS S.A.(NASDAQ: EDAP) shares climbed 17% to $3.10 after the company reported preliminary Q2 sales are up 45% from last year.

* NETGEAR, Inc.(NASDAQ: NTGR) gained 16.4% to $33.02 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 sales guidance on the high end analyst estimates and announced a $4.5 million buyback.

* Meritage Homes Corporation (NYSE:MTH) rose 15.8% to $62.98 after the company reported better-than-expected Q2 EPS and sales results. Citi also upgraded the company's stock from Neutral to Buy.

* ADOMANI, Inc.(NASDAQ: ADOM) jumped 14.8% to $0.2754 after the company reported better-than-expected Q2 sales results. The company also reported a Q2 net loss of $1.3 million vs $4.2 million in the same quarter last year.

* Onconova Therapeutics, Inc.(NASDAQ: ONTX) gained 14.4% to $2.63. Noble Capital initiated coverage on Onconova Therapeutics with an Outperform rating and a $12 price target.

* Live Oak Bancshares, Inc.(NASDAQ: LOB)rose 13.8% to $19.24 following upbeat Q2 earnings.

* Aeglea BioTherapeutics, Inc.(NASDAQ: AGLE) gained 13.3% to $8.10. Aeglea Bio Therapeutics said the FDA granted Breakthrough Therapy Designation to its lead investigational therapy pegzilarginase, for the treatment of Arginase 1 Deficiency, a rare progressive disease presenting in early childhood that results in severe complications and early mortality.

* Pluristem Therapeutics Inc.(NASDAQ: PSTI) climbed 12.6% to $4.7958.

* AgeX Therapeutics, Inc.(NYSE:AGE) rose 11.4% to $2.4850.

* Universal Forest Products, Inc.(NASDAQ: UFPI) rose 9.8% to $39.46 after the company reported better-than-expected Q2 EPS results.

* scPharmaceuticals Inc.(NASDAQ: SCPH) gained 8.9% to $5.74.

* Nokia Corporation(NYSE:NOK) shares rose 8.6% to $5.62 after the company reported better-than-expected Q2 results.

* Ambev S.A.(NYSE:ABEV) climbed 7.8% to $5.10 after the company reported better-than-expected Q2 EPS and sales results.

* TechnipFMC plc(NYSE:FTI) rose 5.7% to $27.88 after the company reported better-than-expected Q2 EPS and sales results.

* AstraZeneca PLC (NYSE:AZN) rose 5.6% to $42.62 after the company reported better-than-expected Q2 EPS and sales results. The company also extended its 2017 development agreement with BioCardia.

* Anheuser-Busch InBev SA/NV(NYSE:BUD) shares rose 3.7% to $99.10 after reporting strong Q2 results.

*

Check out these big penny stock gainers and losers

Losers

* Align Technology, Inc.(NASDAQ: ALGN) shares tumbled 27.4% to $199.72 after the company issued Q3 EPS and sales guidance below analyst estimates. Evercore ISI Group downgraded the company's stock from Outperform to In-Line and lowered the price target from $340 to $220.

* Spirit Airlines, Inc.(NYSE:SAVE) dropped 21.7% to $43.13 after multiple firms downgraded the company's stock following the release of the company's Q2 results.

* World Acceptance Corporation (NASDAQ: WRLD) fell 20.3% to $130.46 following Q1 results. Janney Capital downgraded World Acceptance from Neutral to Sell and lowered the price target from $108 to $87.

* NextGen Healthcare, Inc.(NASDAQ: NXGN) shares declined 20.1% to $16.40 after reporting Q1 results. Dougherty downgraded NextGen Healthcare from Neutral to Sell.

* PTC Inc. (NASDAQ: PTC) fell 19.9% to $73.34 after the company reported Q3 results and lowered its FY19 guidance.

* Lantheus Holdings, Inc.(NASDAQ: LNTH) fell 17.8% to $23.78 after the company reported downbeat Q2 sales and lowered FY2019 guidance.

* Oceaneering International, Inc.(NYSE:OII) fell 17.3% to $15.98 after the company reported worse-than-expected Q2 EPS and sales results.

* LendingTree, Inc.(NASDAQ: TREE) dipped 16.6% to $345.00 after the company reported worse-than-expected Q2 EPS results.

* Martin Midstream Partners L.P.(NASDAQ: MMLP) fell 16.6% to $5.64 after reporting Q2 results.

* Altra Industrial Motion Corp.(NASDAQ: AIMC) dropped 16.4% to $30.06 after the company reported worse-than-expected Q2 EPS and sales results. The company issued FY19 EPS and sales guidance below analyst estimates.

* Flexible Solutions International Inc.(NYSE:FSI) shares declined 16.4% to $3.2776.

* Innoviva, Inc.(NASDAQ: INVA) tumbled 14.5% to $11.14.

* Akerna Corp.(NASDAQ: KERN) dropped 14.2% to $11.73.

* Tesla, Inc.(NASDAQ: TSLA) fell 14% to $227.80 after the company reported worse-than-expected Q2 EPS and sales results.

* Obalon Therapeutics, Inc.(NASDAQ: OBLN) dropped 13.1% to $4.9715.

* Cara Therapeutics, Inc.(NASDAQ: CARA) fell 12% to $23.13. Cara Therapeutics priced its 5.5 million share offering of common stock at $23 per share.

* CoreLogic, Inc.(NYSE:CLGX) dipped 11.6% to $41.75 following Q2 results.

* Antero Resources Corporation (NYSE:AR) dropped 10.5% to $4.4025.

* Unit Corporation(NYSE:UNT) dropped 9.4% to $6.76

* TAL Education Group(NYSE:TAL) fell 9.4% to $33.99 after reporting quarterly results.

* Ford Motor Company(NYSE:F) fell 7.8% to $9.52 after reporting second-quarter earnings. The company issued weak 2019 earnings guidance.

* QIAGEN N.V.(NASDAQ: QGEN) fell 5.7% to $37.80 following Q2 results.

* Banco Bradesco S.A.(NYSE:BBD) dropped 5.3% to $9.72 after the company reported Q2 results.

* American Airlines Group Inc.(NASDAQ: AAL) dropped 4.7% to $32.96 after the company reported Q2 results.

* PayPal Holdings, Inc.(NASDAQ: PYPL) fell 4.2% to $116.25. PayPal reported upbeat earnings for its second quarter, while sales missed estimates. The company also issued 2019 sales guidance below analyst estimates.

* RELX PLC(NYSE:RELX) fell 4.1% to $23.28 following weak sales.

* ServiceNow, Inc.(NYSE:NOW) shares dropped 3.8% to $285.84 after the company reported Q2 results and issued Q3 guidance.

* Xilinx, Inc.(NASDAQ: XLNX) fell 3.4% to $127.68 after the company issued its Q2 sales guidance below analyst estimates.

(c) 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
COPYRIGHT 2019 Accretive Capital LLC dba Benzinga.com
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Benzinga.com
Date:Jul 25, 2019
Words:1322
Previous Article:Rate Cut Minus Recession Equals More Market Gains.
Next Article:Citrix Analyst: 'Near-Term Pain For Long-Term Gain'.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters